VITEK Gram Positive Susceptibility (GPS) Card for Ertapenem
510(k) K042963
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK042963 | Date13 Dec 2004 | StatusActive |
Recalls
No FDA recalls found in the data synced 6 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- LON
- Device Class
- Class II
- Regulation
- 21 CFR Part 866.1645
- Advisory Committee
- Microbiology
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 26 Sep 2026
The VITEK Gram Positive Susceptibility (GPS) Card for Ertapenem is an automated antimicrobial susceptibility test system designed for use with the VITEK System. It is intended as a laboratory aid in the determination of in vitro susceptibility to antimicrobial agents for Gram-positive organisms, including Staphylococcus aureus and Streptococcus agalactiae.
The device is supplied for use in clinical laboratories and is classified as a Class II medical device under product code LON. It received FDA 510(k) clearance (K042963) on December 13, 2004, as substantially equivalent to a legally marketed predicate device. The card is used as instructed in the product labeling for antimicrobial susceptibility testing with short incubation protocols.
Other devices from Biomerieux, Inc.
Questions
AI-generated answers, 26 Sep 2026
What is the VITEK Gram Positive Susceptibility Card for Ertapenem used for?
The VITEK Gram Positive Susceptibility (GPS) Card for Ertapenem is intended as a laboratory aid in the determination of in vitro susceptibility to antimicrobial agents for Gram-positive organisms, including Staphylococcus aureus and Streptococcus agalactiae, when used with the VITEK System.
How is the VITEK GPS Card for Ertapenem supplied and used in the laboratory?
The device is supplied for use in clinical laboratories and is used as instructed in the product labeling for antimicrobial susceptibility testing with short incubation protocols on the VITEK System.
What regulatory pathway was used for the VITEK GPS Card for Ertapenem, and what is its classification?
The device received FDA 510(k) clearance (K042963) on December 13, 2004, as substantially equivalent to a legally marketed predicate device and is classified as a Class II medical device under product code LON.